Article
miRNAs driving diagnosis, prognosis and progression in Merkel cell carcinoma
14 Aug 2023
Abstract excerpt
Merkel cell carcinoma (MCC) is a rare, aggressive form of skin malignancy with a high recurrence commonly within two to three years of initial diagnosis. The incidence of MCC has nearly doubled in the past few decades. Options for diagnosing, assessing, and treating MCC are limited. MicroRNAs (miRNAs) are a class of small, non-coding RNA molecules that play an important role in controlling many different aspects...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
